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Abstract
Purpose: this  study examined if  lower volume exercise-induced muscle damage (EIMD)
performed  two weeks  before  high  volume muscle-damaging  exercise  protects  against  its
detrimental effect on running performance.  Methods: 16 male participants were randomly
assigned to a lower volume (5 sets of 10 squats, n=8) or high volume (10 sets of 10 squats,
n=8) EIMD group and completed baseline measurements for muscle soreness, knee extensor
torque, creatine kinase (CK), a 5-min fixed-intensity running bout and a 3 km running time-
trial. Measurements were repeated 24 and 48 h after EIMD, and the time-trial running after
48 h. Two weeks later, both groups repeated the baseline measurements, 10 sets of 10 squats
and the same follow-up testing (Bout 2). Results: Data analysis revealed increases in muscle
soreness and CK and decreases in knee extensor torque 24 – 48 h after the initial bouts of
EIMD.  Increases  in  oxygen  uptake  ( V˙ O2 ),  minute  ventilation  ( V˙ E )  and  rating  of
perceived exertion (RPE) were observed during fixed-intensity running 24 – 48 h after EIMD
Bout 1. Likewise, time increased, speed and  V˙ O2 decreased during a 3 km running time-
trial 48 h after EIMD. Symptoms of EIMD, responses during fixed-intensity and time-trial
running were attenuated in the days after the repeated bout of high volume EIMD performed
two weeks after  the initial  bout.  Conclusion: this  study demonstrates  that  the protective
effect of lower volume EIMD on subsequent high volume EIMD is transferable to endurance
running. Furthermore, time-trial performance was found to be preserved after a repeated bout
of EIMD. 
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Abbreviations
CK creatine kinase
CO2 carbon dioxide
EIMD exercise-induced muscle damage
EMG electromyography
HR heart rate
[La] blood lactate
LTP lactate turnpoint
MVC maximal voluntary contraction
O2  oxygen
RBE repeated bout effect
RPE rating of perceived exertion
SF stride frequency
SL stride length
VAS visual analogue scale
V˙ E minute ventilation
V˙ O2 oxygen uptake
VL vastus lateralis
VM vastus medialis
V˙ O2 peak peak oxygen uptake
Introduction
It  is  well  established  that  the  signs  and  symptoms  of  exercise-induced  muscle  damage
(EIMD) are attenuated after a repeated bout of muscle-damaging exercise (McHugh 2003;
McHugh et  al.  1999).  These adaptations  are  now known to be extended to the observed
effects  of  EIMD  on  running  performance,  whereby  the  negative  alterations  in  the
physiological, metabolic, perceptual and kinematic responses during fixed-intensity running
are reduced after a repeated bout of EIMD performed two weeks later (Burt et al. 2013). 
An interesting observation is that a prior bout of lower volume EIMD protects the muscle
against damage in the days after high volume muscle-damaging exercise (Brown et al. 1997;
Chen  2003;  Clarkson  and  Tremblay  1988;  Nosaka  et  al.  2001).  Howatson  et  al.  (2007)
demonstrated that 10 maximal eccentric contractions protected the elbow flexors against 45
maximal eccentric contractions performed two weeks later. Using surface EMG, the authors
attributed the ‘repeated bout effect’ (RBE) to a reduction in median freqency. They suggested
that an increased number of more resilient type I fibres were activated to protect the muscle
against  damage  during  the  higher  volume  eccentric  exercise.  However,  it  is  not  known
whether the protective effect of lower volume muscle-damaging exercise performed prior to a
high volume of the same exercise preserves running performance. If it does, this would have
have a ‘real-world’ application for those endurance athletes engaging in periodized resistance
training  for  the  first  time.  That  is  to  say,  where  endurance  athletes  are  contemplating
concurrent  endurance  and  resistance  exercise  to  improve  performance,  performing  lower
volume resistance  exercise  two weeks  before  engaging in  concurrent  training  might pre-
condition the muscle to withstand high bouts of muscle-damaging exercise and its subsequent
effects on endurance performance.
The effects  of EIMD on endurance performance are often examined using fixed-intensity
sub-maximal  workloads  (Braun  and  Dutto  2003;  Burt  et  al.  2013;  Chen  et  al.  2009;
Kyröläinen et al. 2000). Whilst such protocols enable physiological responses to be measured
during steady-state exercise,  they lack ecological  validity  (Currell  and Jeukendrup 2008).
Alternatively, time-trials provide a more appropriate measurement of endurance performance
that is impaired after EIMD. Indeed, decreases in distance covered (~6%), average power
output (~12%) and oxygen cost (~11%) have been observed during cycling and running time-
trials performed after EIMD (Burt and Twist 2011; Marcora and Bosio 2007; Twist and Eston
2009). The mechanims posited to explain the decrement in time-trial performance include an
altered  sense  of  effort,  a  reduction  in  neural  drive  and  an  increased  production  of
inflammatory cytokines (Burt and Twist 2011; Marcora and Bosio 2007; Twist and Eston
2009).  However,  whether  this  reduction  in  time-trial  performance  is  still  evident  after  a
repeated  bout  of  EIMD remains  unknown.  Therefore,  the  aims  of  this  study were  (i)  to
investigate if a lower volume muscle-damaging exercise can protect the muscle against the
detrimental  effects  on  the  physiological,  metabolic,  kinematic  and  perceptual  responses
during fixed-intensity running after subsequent high volume EIMD, and (ii) to examine the
effects of repeated bouts of muscle-damaging exercise on running time-trial performance.
Methods
Participants and experimental design
After institutional ethical approval, 16 healthy male participants (see Table 1), who regularly
participated in endurance exercise (2 – 3 sessions per week) and had not completed any lower
limb resistance exercise in the previous six months, volunteered to participate in  the study.
Prior to data  collection,  participants provided informed consent  and completed a  medical
health  questionnaire.  Participants  were  tested  on  eight  separate  occasions  over  a  5-week
period.  During the initial  visit,  they completed an incremental  exhaustive running test  to
determine  lactate  turnpoint  (LTP)  and  peak  oxygen  uptake  ( V˙ O2 peak ),  followed  by
habituation procedures relating to measures of perceived muscle soreness, peak knee extensor
torque (isometric and isokinetic)  and 3 km running time-trial.  After 48–72 h, participants
completed isometric maximal voluntary contractions (MVCs) of the knee extensors, during
which EMG activity of the vastus medialis (VM) and vastus lateralis (VL) was recorded.
Upon completion, participants were randomly assigned to either a lower volume (Low-High;
n = 8) or high volume (High-High; n = 8) muscle damage group. After a further 48 – 72 h,
participants provided baseline measures for perceived muscle soreness, isokinetic peak knee
extensor torque, creatine kinase (CK) activity, 5-min fixed-intensity running at LTP, a 3 km
running time-trial and either lower or high volume lower limb resistance exercise designed to
develop symptoms of EIMD. Baseline procedures were then repeated 24 and 48 h later, with
the exception of the time-trial at 24 h. Two weeks later, when symptoms associated with the
initial bout of muscle damage had disapated (Hortobagyi et al. 1998), participants repeated
the baseline procedures, a repeated bout of high volume muscle-damaging exercise and the
same follow-up testing at 24 and 48 h (except for the time-trial at 24 h). Participants were
requested to avoid exercise 24 h prior to each visit, maintain their normal diets and avoid
using any analgesic agents.
***Insert Table 1 here***
Procedures 
Assessment of lactate turnpoint and peak oxygen uptake
Incremental  running  to  determine  individual  LTP  and  V˙ O2 peak  was  performed  on  a
motorized treadmill (Woodway PPS 55sport-I, Woodway GmbH, Germany). Running speed
commenced at 9 km.h-1 and was increased by 1.0 km.h-1 every 4 min until participants reached
volitional exhaustion. Fingertip capillary blood samples were taken at the end of each 4-min
stage and immediately analyzed for blood lactate ([La]) (Lactate Pro analyser, Arkray, Kyoto,
Japan). Lactate turnpoint was confirmed as the speed at which a second rise in [La] occurred
above baseline values (Jones et al., 2009). Expired air was collected continuously using an
online metabolic system (Oxycon Pro, Hoechberg, Germany) that was calibrated prior to each
test with a span gas mixture of 16% O2  and 5% CO2 . Gas exchange variables (including
V˙ O2 )  were recorded breath-by-breath and later  averaged over  30 s  epochs.  Heart  rate,
monitored via telemetry (Polar Electro, Polar Beat, Oy, Finland), and ratings of perceived
exertion  (RPE;  Borg 1998) were recorded in  the  final  15  s  of  each  stage.  V˙ O2 peak was
accepted as the highest  V˙ O2  averaged over 30 s. Reliability data for V˙ O2 peak and HR at
exhaustion demonstrated a coefficient of variation (CV) of 3.5% and 2.4%, respectively.
Indirect markers of muscle damage
After squatting to a knee angle of 90o, participants indicated the perceived soreness felt in
their knee extensors by moving a marker along a visual analogue scale (VAS). The VAS
comprised written cues from left (no muscle soreness) to right (muscles too sore to move),
which corresponded to a number (0-10 unseen by the participant) on the reverse side. This
scale has been used successfully in previous research (Twist & Eston 2009) and has been
established as a valid and reliable measurement tool of soreness (Price et al. 1983).
To assess muscle function after the initial and repeated bouts of EIMD, isokinetic peak knee
extensor torque was determined from the dominant limb using an isokinetic dynamometer
(Biodex  3,  Biodex  Medical  Systems,  Shirley,  NY,  USA).  After  a  standardized  warm-up
comprising 3 min of sub-maximal cycling at 50 W and five sub-maximal and one maximal
familiarization trials, participants performed five maximal efforts at a velocity of 60 deg .s-1.
The highest of the five contractions was accepted as the peak isokinetic knee extensor torque.
Visual  feedback  and  consistent  encouragement  were  used  during  each  test  to  promote
maximal effort. Institutional reliability data for peak isokinetic knee extensor torque at 60
degs.s-1 revealed a CV of 4.9%.   
After pre-warming the hand in warm water (~42oC), a 30 µl sample of fingertip capillary
whole blood was collected, pipetted to a test strip, separated for plasma and analyzed for CK
using  a  colorimetric  assay  procedure  (Reflotron,  Boehringer  Mannheim,  Germany).
Reliability data for CK revealed a CV of 10.9%.  
Fixed-intensity running and stride pattern
Participants performed 5 min of fixed-intensity running at their previously determined LTP
on a motorized treadmill (Woodway PPS 55sport-I, Woodway GmbH, Germany). Expired air,
heart  rate  (HR),  RPE and [La]  were  recorded as  previously  described above.  Reliability,
assessed using CV, determined errors of 3.3%, 5.4%, 2.3%, 3.8%, and 6% for V˙ O2 , V˙ E ,
HR, RPE, and [La], respectively. The final 10 s of each 5-min running bout was recorded
using  a  high  speed  video  camera  (Casio  Exilim,  Pro  Ex-F1)  and  then  downloaded  and
digitized using motion analysis software (Qunitec Biomechanics 9.03 v 14). Stride length
(SL) and stride frequency (SF) during each running bout were determined from the methods
previously described by Braun and Dutto (2003) and Chen et al. (2009). In brief, SL for each
full stride was calculated from the formula: SL (m) = velocity (m .s-1) x stride time (s), with an
average  SL used  for  analysis.  Stride  frequency  was  determined  by  measuring  the  time
between the first and last heel contacts, and then dividing the number of full strides by time.
For example, if 12 full strides were completed in 9.4 s, 12.8 strides would be completed in 10
s. Reliability data for SL and SF revealed a CV of 1.2% and 1% respectively.     
Electromyography
During each fixed-intensity running bout, surface EMG (Noraxon, Scottsdale, AZ, USA) was
recorded from the VM and VL. The location of each muscle site was in accordance with the
“Surface  EMG  for  Non-Invasive  Assessment  of  Muscles”  (SENIAM)  recommendations
(Hermens  et  al.  1999).  Briefly,  electrodes  for  the  VM were  placed  at  four-fifths  of  the
distance between the anterior superior iliac spine and the joint space in front of the anterior
border of the medial ligament. The VL electrode site was located at two-thirds of the distance
from the anterior superior iliac spine and the lateral side of the patella. A ground reference
electrode  was  placed  over  the  tibia.  Before  the  placement  of  electrodes,  body  hair  was
removed, the skin lightly abraded and cleansed with an alcohol swab. After the first trial, the
position of each electrode was marked with permanent ink to ensure the same placement
across  the  bouts.  In  agreement  with  recommendations  from  SENIAM,  dual  silver/silver
chloride electrodes (10 mm diameter contact area, 20 mm inter-electrode distance and 40 mm
x 22 mm adhesive gel surface) were aligned with the orientation of the muscle fibre. Once in
place, the electrode-skin impedance was checked before each trial to ensure it was < 10 KΩ.
Electrodes were connected, via wires with built-in pre-amplifiers, to a transmitter unit that
relayed  data  to  an  analogue-to-digital  converter  through  telemetry.  The  wires  and  pre-
amplifiers were taped to the skin to prevent any movement artefact. The raw EMG signals
were sampled at a frequency of 1500 Hz, amplified by 500 and underwent a 12-bit analog-to-
digital conversion. The common mode rejection ratio was > 100 dB, the baseline noise < 2
µV and the input impedance > 10 MΩ (Konrad 2005). Data were collected during all of the
5-min fixed-intensity running bouts, with the last 10 contractions analyzed for peak EMG
amplitude. To calculate the peak EMG amplitude, the raw data were full-wave rectified using
root mean squared averaging with a 50 ms time window and then filtered with a band-pass of
10 – 500 Hz (Konrad 2005). All peak EMG amplitude data was normalized by dividing the
value during each fixed-intensity running bout by the peak EMG amplitude obtained during
isometric  MVCs  of  the  knee  extensors  (Ansley  et  al.  2004).  Peak  isometric  force  was
measured  from the  dominant  limb at  an  angle  of  80°  using  the  isokinetic  dynamometer
described above (Byrne et al. 2001). After five sub-maximal and one maximal familiarization
trials, participants performed two MVC trials of 3 s duration, with a 60 s rest between each
(Byrne et al. 2001).
Three kilometre time-trial protocol
Participants were required to complete  3 km in the quickest time possible on a motorized
treadmill  (Woodway  PPS  55sport-I,  Woodway  GmbH,  Germany).  Feedback  on  distance
covered  was freely available,  however  participants were not  able  to  view time,  treadmill
speed  or heart  rate. As previously described by Marcora and Bosio (2007), the time-trial
commenced with the participants standing on the treadmill whilst the speed was increased to
9 km.h-1. Once this speed was attained, participants were able to adjust the speed freely. Time,
RPE and a fingertip capillary sample analyzed for [La] were collected upon completion of the
time-trial. Expired air and HR were measured throughout the time trial, with mean V˙ O2 and
HR determined for analysis. Average speed was calculated as distance divided by time.  
Exercise-induced muscle damage protocol
The  muscle-damaging  protocol  required participants  to  perform  Smith-machine  assisted
squats at a resistance corresponding to 80% of body mass. The Low-High group completed
an initial bout of resistance exercise comprising 5 sets of 10 squats, followed two weeks later
by a high volume bout of 10 sets of 10 squats. The High-High group completed an initial bout
of 10 sets of 10 squats, followed two weeks later by repeating the same high volume bout.
Each  set  was  interspersed  with  a  2-min  rest  period.  Before  the  exercise,  participants
performed an unloaded squat during which a goniometer (Cranlea and Co., Birmingham, UK)
was used to determine a 90o knee angle.  Markers were then placed on either side of the
Smith-machine  to  ensure  that  the  range  of  motion  was  maintained  during  the  squatting
protocol and between bouts. The bar was positioned on the participant’s shoulders, with his
back straight, legs fully extended and feet hip-width apart. The eccentric phase of the squat
involved lowering the bar until a knee angle of 90o was achieved. Participants then lifted the
bar back to the starting position to complete the concentric phase. To stress the eccentric
component, participants were instructed to ensure that the downward and upward phases of
the squat lasted for 2 and 1 s, respectively. Previous research has shown this protocol to be
successful  in  inducing symptoms of  muscle  damage to the  knee extensors  (Davies  et  al.
2009). 
Statistical analysis
Descriptive statistics (mean  ± SD) were calculated for all performance variables. To assess
the variability of the indirect markers of EIMD and dependent variables during the fixed-
intensity running protocol, a series of separate three-way mixed factor (Group [2] x Bout [2]
x Time [3]) repeated measures ANOVAs were used. The dependant variables during the time-
trial were also analyzed using a mixed factor ANOVA (Group [2] x Bout [2] x Time [2]).
Assumptions of sphericity were assessed using Mauchly’s test, with any violations adjusted
via the Greenhouse-Geisser correction. Where significant interaction effects were observed,
independent t-tests were used to identify pair-wise differences. The alpha level was set at P <
0.05.
Results
Indirect markers of muscle damage
Perceived muscle soreness demonstrated a significant Bout (F(1,14) = 33.9,  P ≤ 0.0005) and
Bout x Time (F(2,28) = 24.3, P ≤ 0.0005) effect, however, no significant Group x Bout x Time
interaction  was  observed.  Similarly,  there  was  no  Group  x  Bout  x  Time  interaction  for
isokinetic peak knee extensor torque, although Bout (F(1,14) = 15.4,  P = 0.002) and Bout x
Time (FGG(1.2,16.2) = 11.6,  P = 0.003) effects were observed. CK activity changed over Bout
(F(1,14) = 28.2, P ≤ 0.0005) and across Bout x Time (FGG(1.2,17.3) = 37.8, P ≤ 0.0005). A Group x
Bout  x  Time interaction  (FGG(1.2,17.3) =  7.9,  P =  0.009)  was  also  observed,  with  post  hoc
analysis revealing that CK activity was significantly greater in the High-High group at 24 and
48 h after Bout 1 (Figure 1).
***Insert Figure 1 here***
Fixed-intensity running responses to repeated bouts of muscle-damaging exercise
Most  of  the  physiological,  metabolic  perceptual  and  kinematic  responses  during  fixed-
intensity running revealed significant Bout ( V˙ O2  (F(1,14) = 30.2, P ≤ 0.0005); V˙ E  (F(1,14)
= 9.4, P = 0.008); [La] (F(1,14) = 25.4, P ≤ 0.0005); RPE (F(1,14) = 20.1, P = 0.001); SL (F(1,14) =
34.2, P ≤ 0.0005); SF (F(1,14) = 36.5, P ≤ 0.0005)) and Bout x Time effects (
V˙ O2  (F(2,28) =
16.1,  P ≤ 0.0005);  V˙ E  (F(2,28) = 18.2,  P ≤ 0.0005); [La] (F(2,28) = 5.9,  P = 0.007); RPE
(F(2,28) = 25.6,  P ≤ 0.0005); SL (F(2,28) = 13.7,  P ≤ 0.0005); SF (F(2,28) = 15.2,  P ≤ 0.0005)).
Heart  rate  demonstrated a  Bout  effect  (F(1,14) =  7.1,  P =  0.019)  only.  There  was also no
significant Group x Bout x Time effect on V˙ O2 , V˙ E , [La], RPE, HR, SL or SF (Table
2).
***Insert Table 2 here***
Electromyography
Peak EMG amplitude of the VM demonstrated Bout (F(1,14) = 17.5,  P = 0.001) and Bout x
Time (F(2,28) = 9.8, P = 0.001) effects only, whilst Peak EMG amplitude of the VL was only
significant across Bouts (F(1,14) = 27.4, P ≤ 0.0005; Table 3). 
***Insert Table 3 here***
Time trial responses to repeated bouts of muscle-damaging exercise
All of the dependent variables during the running time-trial, except for end RPE, revealed a
significant main effect of Bout (time (F(1,14) = 39.3, P ≤ 0.0005); average speed (F(1,14) = 29.9,
P ≤ 0.0005); mean V˙ O 2 (F(1,14) = 15.9, P = 0.001); end [La] (F(1,14) = 33.8, P ≤ 0.0005); mean
HR (F(1,14) = 7.2, P = 0.018)) and an interaction effect of Bout x Time (time (F (1,14) = 29.7, P ≤
0.0005); average speed (F(1,14) = 25.5,  P ≤ 0.0005); mean 
V˙ O2  (F(1,14) = 19.1,  P = 0.001);
end [La] (F(1,14) = 15.2, P = 0.002); mean HR (F(1,14) = 21.1, P ≤ 0.0005)). Furthermore, there
was no significant interaction of Group x Bout x Time on time, average speed, mean V˙ O2 ,
end [La], end RPE or mean HR (Fig. 2).
***Insert Figure 2 here***
Discussion
The  initial  bout  of  squatting  exercise,  independent  of  volume,  resulted  in  symptoms  of
exercise-induced muscle damage. Both groups experienced heightened perceptions of muscle
soreness, decreases in peak knee extensor torque and increases in CK activity in the 24 and
48 h after lower or high volume squats. Nonetheless, symptoms of EIMD were attenuated in
the  days  after  the  second bout  of  muscle-damaging exercise.  Furthermore,  this  reduction
occurred  regardless  of  whether  participants  performed  lower  or  high  volume  squatting
exercise in Bout 1, and reaffirms previous observations that lower volume resistance exercise
protects the muscle against high volume muscle-damaging exercise (Brown et al. 1997; Chen
2003; Clarkson and Tremblay 1988; Howatson et al. 2007; Nosaka et al. 2001). 
As expected,  the physiological,  metabolic and perceptual responses during fixed-intensity
running were altered in the days after Bout 1. Each group displayed increases in  V˙ O 2 ,
V˙ E , [La], and RPE during fixed-intensity running at 24 and 48 h after the initial bout of
EIMD. We postulate that muscle soreness experienced after the initial squatting bout was
responsible for the increase in V˙ O2  and V˙ E  during fixed-intensity running. In attempts to
limit  discomfort  associated  with  muscle  soreness,  participants  might  have  altered  their
running stride pattern (as shown by changes in SL and SF), leading to the increase in V˙ O2
(Braun & Dutto 2003). Furthermore, the activation of group III and IV afferent fibres, which
are responsible  for muscle  soreness,  might have provided an additional stimulus to drive
V˙ E  during fixed-intensity running (Davies et al. 2009). The elevated V˙ E  response could
also  explain  the concomitant  increase in  RPE during fixed-intensity  running.  Feelings  of
breathlessness might have provided a central cue to inform RPE, whilst it is also possible that
muscle soreness experienced in the knee extensors provided a peripheral cue to alter the sense
of effort (Davies et al. 2009; Jameson and Ring 2000; Twist and Eston 2009).
This is  the first  study to confirm that EMG amplitude is  increased during fixed-intensity
running after EIMD. Given that knee extensor strength had decreased after the initial lower
(~11%) and higher volume (~16%) squatting exercise, a compensatory increase in motor unit
recruitment  occurred  to  ensure  that  participants  were  able  to  complete  the  same running
speed  (Kyröläinen  et  al.  2000).  Moreover,  the  compensatory  increase  in  central  motor
command could also explain the elevation in  V˙ O2 , [La], and RPE during fixed-intensity
running after the initial bout of EIMD. Indeed, since there is a linear relationship between
EMG activity and oxygen uptake (Bigland-Ritchie and Woods 1974), it is plausible that the
observed  increase  in  V˙ O2  was  reflective  of  an  increase  in  EMG  amplitude.  RPE  is
described as a ‘sensation of innervation’ generated by the conscious awareness of the central
motor  command  sent  to  the  exercising  muscle  (Marcora  2009).  Therefore,  the  increased
motor unit recruitment required to produce the same baseline running speed after Bout 1
could also explain the elevation in RPE. Likewise, the observed increase in EMG activity
might reflect an increase in the recruitment of non-damaged, more glycolytic, type II fibres,
which caused the increase in [La] during fixed-intensity running after Bout 1 (Braun and
Dutto 2003). 
The detrimental effects of muscle-damaging exercise on fixed-intensity running were less
prominent  after  a  repeated  bout  performed two weeks later  (i.e.  Bout  2).  These findings
occurred irrespective of the initial volume of EIMD and endorse those of Burt et al. (2013). It
is likely that the initial bout strengthened muscle fibre integrity, which subsequently reduced
muscle soreness and maintained muscle function after the repeated bout. This enabled the
preservation of stride pattern and motor unit activation during fixed-intensity running, and
possibly explains why V˙ O2 , V˙ E , [La], and RPE remained unchanged after Bout 2.
For the first time, this study reports on the effects of repeated bouts of muscle-damaging
exercise on running time-trial performance. As anticipated, running time-trial performance
was impaired after the initial bout of resistance exercise, where the time to complete 3 km
was  increased  by  7%  and  9%  after  lower  and  high  volumes  of  damaging  exercise,
respectively.  This  corresponds  with  previous  studies,  whereby  distance  covered  during
cycling (Burt and Twist 2011; Twist and Eston 2009) and running (Marcora and Bosio 2007)
time-trials is decreased by 4 – 6% as a result of EIMD. However, this is the first study to
demonstrate that the detrimental effects of EIMD on running time-trial performance are less
prevalent after a second bout. 
In support of Marcora and Bosio (2007),  participants in our study ran at  a slower speed
despite  their  RPE  being  similar  to  pre-damage  during  the  time-trial  after  Bout  1.  It  is
speculated that muscular pain incurred as a result of the initial bout of squatting exercise
altered the sense of effort  during the time-trial,  which resulted in participants adopting a
slower speed and the subsequent lower V˙ O2 , V˙ E , HR and [La] responses. The absence of
any increase in muscle soreness as a result of the RBE would have enabled the same sense of
effort  during the  time-trial  after  Bout  2,  which  meant  time,  speed,  V˙ O2 ,  HR and [La]
remained unaltered.
What is also original from this study is that the responses after a second bout of damaging
exercise were not different between the Low-High and High-High groups. This informs that
the physiological, metabolic and perceptual responses during fixed-intensity and time-trial
running after repeated bouts of higher volume EIMD were attenuated independent of whether
this was preceded by lower or high volume muscle-damaging exercise. 
We can only speculate about the possible mechanisms of action that explain how initial lower
or high volume damaging exercise results in a similar RBE. CK activity after the second bout
of high volume squatting was reduced by the initial lower volume bout, meaning it is unlikely
that the RBE was exclusively due to the removal and replacement of weak sarcomeres as
proposed by some studies (e.g. Armstrong et al. 1983; Byrnes et al. 1985; McHugh et al.
2003;  McHugh et  al.  1999).  Indeed,  if  weak sarcomeres  were still  intact  after  the lower
volume bout of squatting then they would have been damaged during the more strenuous high
volume bout (Nosaka et al. 2001). Therefore, the lower CK in Bout 2 suggests that the initial
stress in Bout 1, albeit of a lower intensity, provided a stimulus to strengthen the muscle cell
membrane against further damage (Clarkson and Tremblay 1988; Howatson et al. 2007). The
protective effect of lower volume muscle-damaging exercise against subsequent high volume
exercise could also be due to changes in  motor unit  recruitment during squatting Bout  2
(Chen 2003; Howatson et al. 2007; McHugh 2003; McHugh et al. 1999). Unfortunately EMG
activity was measured during running and not the damaging exercise, which means that we
are unable to confirm if alterations in motor unit activity occurred.
Despite being the first study to demonstrate that motor unit recruitment during endurance
exercise is altered by EIMD, we recognise the limitations of surface EMG. Attempts were
made to ensure accurate placement of electrodes on the skin surface, but despite this control,
we accept that changes in pH and blood flow might have occurred between visits (Kupa et al.
1995). Moreover, we also acknowledge that the extent of EIMD amongst individuals was
variable.  Although  the  group  means  revealed  a  significant  effect  after  EIMD,  the  large
standard deviations on most dependent variables suggest that some participants demonstrated
a  greater  susceptibility  to  EIMD than  others.  This  inter-individual  response  to  EIMD is
common and might reside in certain genetic polymorphisms (Hubal et al. 2010). 
Conclusions
This  investigation reaffirms that  EIMD causes alterations  to fixed-intensity  and time-trial
running performance. However, lower volume muscle-damaging exercise (5 sets of 10 squats
at 80% body mass) provides protection against a high volume bout (10 sets of 10 squats at
80% body mass) performed two weeks later. Furthermore, in the days after this repeated bout
of EIMD, symptoms of muscle damage and alterations to fixed-intensity and 3 km time-trial
running  were  all  reduced.  From  a  practical  standpoint,  where  endurance  athletes  are
contemplating concurrent  endurance and resistance exercise to  enhance performance,  this
study shows that performing lower volume resistance exercise pre-conditions the muscle to
withstand  high  bouts  of  muscle-damaging  exercise  and  its  detrimental  effects  on  fixed-
intensity and time-trial running. 
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Table 1. 
Low-High (n = 8) High-High (n = 8)
Age (y) 26 ± 5 27 ± 4
Stature (m) 1.79 ± 0.05 1.77 ± 0.1
Body Mass (kg) 79.5 ± 7.8 76.7 ± 9.8
V˙ O2 peak  (ml.kg-1.min-1)
54.8 ± 3.5 54.2 ± 4.1
HRpeak (b.min-1) 191 ± 10 191 ± 9
LTPspeed (km.h-1) 12.4 ± 1.1 12.6 ± 0.9 

Table 2. 
Low-High High-High
Variable Bout Baseline 24 48 h Baseline 24 h 48 h
V˙ O2  (ml.kg-1.min-1) ‡ #
1 46.9 ± 2.3 48.7 ± 3.1 48.9 ± 3.0 47.3 ± 2.8 49.5 ± 2.7 49.9 ± 3.1
2 46.7 ± 2.4 47.1 ± 2.5 46.9 ± 2.7 47.5 ± 2.8 47.4 ± 3.1 47.4 ± 2.8
V˙ E  (l.min-1) ‡ #
1 101.3 ± 11.7 110.8 ± 12.4 109.3 ± 12.4 101.3 ± 21.9 112.4 ± 26.5 114.3 ± 26.3
2 102.6 ± 11.8 104.4 ± 10.9 103.3 ± 11.9 100.3 ± 16.3 102.9 ± 15.6 103.1 ± 18.4
[La] (mmol.l-1) ‡ # 1 4.8 ± 1.0 5.5 ± 1.2 5.1 ± 1.2 5.7 ± 1.5 6.1 ± 1.4 6.6 ± 1.8
2 4.6 ± 1.1 4.8 ± 1.1 4.6 ± 1.0 5.6 ± 1.6 5.7 ± 1.6 5.7 ± 1.4
RPE ‡ # 1 12.6 ± 0.9 14.1 ± 1.1 13.8 ± 1.0 13.0 ± 1.5 14.8 ± 1.6 14.3 ± 1.6
2 12.6 ± 0.7 12.9 ± 1.1 12.6 ± 0.7 13.3 ± 1.2 13.5 ± 1.3 13.5 ± 1.3
HR (b.min-1) ‡ 1 163.4 ± 11.6 166.4 ± 11.5 165.8 ± 11.2 172.5 ± 10.2 172.9 ± 11.2 173.5 ± 9.5
2 163.3 ± 11.4 164.5 ± 10.1 163.9 ± 10.0 170.8 ± 11.0 171.0 ± 11.6 171.3 ± 11.1
SL (m-1)  ‡ # 1 2.39 ± 0.17 2.33 ± 0.19 2.33 ± 0.18 2.43 ± 0.20 2.35 ± 0.19 2.33 ± 0.18
2 2.41 ± 0.18 2.40 ± 0.18 2.40 ± 0.18 2.45 ± 0.21 2.44 ± 0.20 2.43 ± 0.20
SF ‡ # 1 14.4 ± 1.1 14.8 ± 1.2 14.8 ± 1.2 14.5 ± 0.8 14.9 ± 0.7 15.1 ± 0.7
2 14.3 ± 1.1 14.3 ± 1.1 14.4 ± 1.1 14.4 ± 0.8 14.4 ± 0.8 14.5 ± 0.8
 
Table 3. 
Low-High High-High
Variable Bout Baseline 24 h 48 h Baseline 24 h 48 h
EMG Peak VM (%) ‡ # 1 66.8 ± 22.3 72.5 ± 24.4 71.0 ± 22.3 49.3 ± 14.7 62.6 ± 15.0 59.8 ± 19.4
2 66.2 ± 21.9 63.3 ± 21.5 65.5 ± 23.0 50.2 ± 20.7 48.4 ± 18.0 48.1 ± 17.8
EMG Peak VL (%) ‡ 1 68.8 ± 17.3 72.4 ± 14.7 71.4 ± 11.6 52.0 ± 13.0 57.0 ± 17.0 56.7 ± 14.4
2 61.8 ± 16.1 62.0 ± 14.7 61.5 ± 13.8 51.8 ± 15.5 51.2 ± 7.7 48.6 ± 11.1
Table legends
Table 1. Participant characteristics
Table 2. Mean (± SD) physiological, metabolic, perceptual and kinematic responses during 
fixed-intensity running after repeated bouts of muscle-damaging exercise. ‡ significant effect 
for Bout; Bout 1 > Bout 2 (P < 0.05). # significant Bout x Time interaction; values 24 – 48 h 
after Bout 1 > values 24 – 48 h after Bout 2 (P < 0.05).
Table 3. Mean (± SD) peak EMG amplitude responses during fixed-intensity running after 
repeated bouts of muscle-damaging exercise. ‡ significant effect for Bout; Bout 1 > Bout 2 
(P < 0.05). # significant Bout x Time interaction; values 24 – 48 h after Bout 1 > values 24 – 
48 h after Bout 2 (P < 0.05).
Figure legends
Figure 1.  Changes in  a perceived muscle sorness,  b knee extensor torque and  c CK after
repeated bouts of muscle-damaging exercise. Values are shown as means ± SD. ‡ denotes a
significant effect for Bout; Bout 1 > Bout 2 (P < 0.05). # denotes a significant Bout x Time
interaction; values 24 – 48 h after Bout 1 > values 24 – 48 h after Bout 2 (P < 0.05). *
denotes a Group x Bout x Time interaction; High-High group > Low-High Group at 24 – 48 h
after Bout 1 (P < 0.05).
Figure 2. Changes in a time, b average speed, c mean V˙ O2 , d mean heart rate, e end blood
lactate and  f end RPE during time-trial running after repeated bouts of EIMD. Values are
shown as means ± SD. ‡ significant effect for Bout; Bout 1 > Bout 2 (P < 0.05). # significant
Bout x Time interaction; values 24 – 48 h after Bout 1 > values 24 – 48 h after Bout 2 (P <
0.05).
